10-K Filing

RELMADA THERAPEUTICS, INC. CIK: 1553643 FY 2017

Filing Information

Form Type	10-K
Accession Number	`0001213900-17-010097`
Period End Date	20170630
Filing Date	20170928
Fiscal Year	2017
Fiscal Period	FY
XBRL Instance	rlmd-20170630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 64 Income Statement 26 Cash Flow Statement 56 Stockholders Equity 16

Balance Sheet 64 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.71M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$22.47M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$8.50M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Other receivable	`OtherReceivablesNetCurrent`	$232.60K	USD	Point-in-time
Other receivable	`OtherReceivablesNetCurrent`	$231.94K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Lease payments receivable - short term	`LeaseIncentiveReceivableCurrent`	$59.32K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Lease payments receivable - short term	`LeaseIncentiveReceivableCurrent`	-	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$472.49K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$566.15K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	12.53M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	12.04M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$2.47M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$9.30M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	12.53M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	12.04M	shares	Point-in-time
Fixed assets, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	$531.35K	USD	Point-in-time
Fixed assets, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	$2.31K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$414.36K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$21.96K	USD	Point-in-time
Lease payments receivable - long term	`LeaseIncentiveReceivableNoncurrent`	-	USD	Point-in-time
Lease payments receivable - long term	`LeaseIncentiveReceivableNoncurrent`	$337.73K	USD	Point-in-time
Total assets	`Assets`	$10.24M	USD	Point-in-time
Total assets	`Assets`	$2.84M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$529.56K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.26M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$634.85K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$394.56K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$276.67K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$273.67K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$892.50K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$175.85K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.38M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.06M	USD	Point-in-time
Long-term liabilities	`OtherLiabilitiesNoncurrent`	-	USD	Point-in-time
Long-term liabilities	`OtherLiabilitiesNoncurrent`	$140.91K	USD	Point-in-time
Total liabilities	`Liabilities`	$1.38M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.20M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, value	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, value	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value, 100,000,000 shares authorized, 12,528,374 and 12,035,037 shares issued and outstanding, respectively	`CommonStockValue`	$12.04K	USD	Point-in-time
Common stock, $0.001 par value, 100,000,000 shares authorized, 12,528,374 and 12,035,037 shares issued and outstanding, respectively	`CommonStockValue`	$12.53K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$86.13M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$86.83M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-79.10M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-85.38M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$1.46M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$8.81M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$7.04M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$10.24M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$2.84M	USD	Point-in-time

Income Statement 26 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$1.29M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$6.21M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$5.93M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$10.01M	USD	Annual
Total operating expenses	`OperatingExpenses`	$7.22M	USD	Annual
Total operating expenses	`OperatingExpenses`	$16.22M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-16.22M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-7.22M	USD	Annual
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$13.11M	USD	Annual
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$716.65K	USD	Annual
Interest (expense) income, net	`InterestIncomeExpenseNet`	$-550.00	USD	Annual
Interest (expense) income, net	`InterestIncomeExpenseNet`	$1.75K	USD	Annual
Sublease income	`SubleaseIncome`	$211.02K	USD	Annual
Sublease income	`SubleaseIncome`	$130.27K	USD	Annual
Gain on assignment of office lease	`GainOnAssignmentOfOfficeLease`	-	USD	Annual
Gain on assignment of office lease	`GainOnAssignmentOfOfficeLease`	$101.60K	USD	Annual
Loss on sales-type lease of fixed assets	`LossOnSalesTypeLeaseOfFixedAssets`	-	USD	Annual
Loss on sales-type lease of fixed assets	`LossOnSalesTypeLeaseOfFixedAssets`	$96.40K	USD	Annual
Total other income	`OtherNonoperatingIncomeExpense`	$932.31K	USD	Annual
Total other income	`OtherNonoperatingIncomeExpense`	$13.24M	USD	Annual
Net loss	`NetIncomeLoss`	$-6.29M	USD	Annual
Net loss	`NetIncomeLoss`	$-2.97M	USD	Annual
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.52	USD	Annual
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.26	USD	Annual
Weighted average number of common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	12.07M	shares	Annual
Weighted average number of common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	11.60M	shares	Annual

Cash Flow Statement 56 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-6.29M	USD	Annual
Net loss	`NetIncomeLoss`	$-2.97M	USD	Annual
Depreciation expense	`Depreciation`	$85.27K	USD	Annual
Depreciation expense	`Depreciation`	$54.82K	USD	Annual
Stock-based compensation	`AllocatedShareBasedCompensationExpense`	$1.21M	USD	Annual
Stock-based compensation	`AllocatedShareBasedCompensationExpense`	$704.45K	USD	Annual
Loss on sales-type lease of fixed assets	`GainLossOnDispositionOfIntangibleAssets`	$-96.40K	USD	Annual
Loss on sales-type lease of fixed assets	`GainLossOnDispositionOfIntangibleAssets`	-	USD	Annual
Gain on lease assignment	`GainOnLeaseAssignment`	$101.60K	USD	Annual
Gain on lease assignment	`GainOnLeaseAssignment`	-	USD	Annual
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$13.11M	USD	Annual
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$716.65K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesOther`	$-370.33K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesOther`	$-1.19M	USD	Annual
Other receivable	`IncreaseDecreaseInOtherReceivables`	$231.94K	USD	Annual
Other receivable	`IncreaseDecreaseInOtherReceivables`	$655.00	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	-	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-392.39K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-730.15K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$424.43K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$152.59K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-279.61K	USD	Annual
Long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$140.91K	USD	Annual
Long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	-	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-6.47M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-13.14M	USD	Annual
Purchase of fixed assets	`PaymentsToAcquireProductiveAssets`	$562.26K	USD	Annual
Purchase of fixed assets	`PaymentsToAcquireProductiveAssets`	$49.69K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-49.69K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-562.26K	USD	Annual
Payment on notes payable	`RepaymentsOfNotesPayable`	$263.75K	USD	Annual
Payment on notes payable	`RepaymentsOfNotesPayable`	$273.67K	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-263.75K	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-273.67K	USD	Annual
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-6.79M	USD	Annual
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-13.97M	USD	Annual
Cash and cash equivalents at beginning of the year	`CashAndCashEquivalentsAtCarryingValue`	$1.71M	USD	Point-in-time
Cash and cash equivalents at beginning of the year	`CashAndCashEquivalentsAtCarryingValue`	$22.47M	USD	Point-in-time
Cash and cash equivalents at beginning of the year	`CashAndCashEquivalentsAtCarryingValue`	$8.50M	USD	Point-in-time
Cash and cash equivalents at end of the year	`CashAndCashEquivalentsAtCarryingValue`	$1.71M	USD	Point-in-time
Cash and cash equivalents at end of the year	`CashAndCashEquivalentsAtCarryingValue`	$22.47M	USD	Point-in-time
Cash and cash equivalents at end of the year	`CashAndCashEquivalentsAtCarryingValue`	$8.50M	USD	Point-in-time
Income taxes	`IncomeTaxesPaidNet`	-	USD	Annual
Income taxes	`IncomeTaxesPaidNet`	-	USD	Annual
Interest	`InterestPaid`	$3.09K	USD	Annual
Interest	`InterestPaid`	$2.65K	USD	Annual
Notes payable issued in connection with director and officer insurance policies	`IssuanceOfDebtInConnectionWithCompensationPolicy`	$273.67K	USD	Annual
Notes payable issued in connection with director and officer insurance policies	`IssuanceOfDebtInConnectionWithCompensationPolicy`	$276.67K	USD	Annual
Cashless exercise of warrants for Common Stock	`CashlessExerciseOfWarrantsForCommonStock`	$1.09K	USD	Annual
Cashless exercise of warrants for Common Stock	`CashlessExerciseOfWarrantsForCommonStock`	$487.00	USD	Annual
Conversion of Class A Preferred Stock to Common Stock	`ConversionOfStockAmountConverted1`	$72.00	USD	Annual
Conversion of Class A Preferred Stock to Common Stock	`ConversionOfStockAmountConverted1`	-	USD	Annual
Issuance of restricted stock for service	`IssuanceOfRestrictedStockForService`	$6.00	USD	Annual
Issuance of restricted stock for service	`IssuanceOfRestrictedStockForService`	$28.00	USD	Annual
Reclassification of long-term liabilities to accrued expense	`ReclassificationOfLongTermLiabilitiesAccruedExpense`	-	USD	Annual
Reclassification of long-term liabilities to accrued expense	`ReclassificationOfLongTermLiabilitiesAccruedExpense`	$39.38K	USD	Annual

Stockholders Equity 16 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquity`	$1.46M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$8.81M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$7.04M	USD	Point-in-time
Issuance of common stock for services	`StockIssuedDuringPeriodValueIssuedForServices`	$204.53K	USD	Annual
Issuance of restricted common stock	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	Annual
Issuance of restricted common stock	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$704.45K	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$1.00M	USD	Annual
Issuance of common stock for cashless exercises of warrants from consultants and Series A Preferred Stock warrant holder	`IssuanceOfCommonStockForExercisesOfWarrantsFromConsultantsAndSeriesPreferredStockWarrantHolder`	-	USD	Annual
Issuance of common stock for cashless exercises of warrants from consultants and Series A Preferred Stock warrant holder	`IssuanceOfCommonStockForExercisesOfWarrantsFromConsultantsAndSeriesPreferredStockWarrantHolder`	-	USD	Annual
Conversion of Class A Preferred Stock to Common Stock	`StockIssuedDuringPeriodValueConversionOfUnits`	-	USD	Annual
Net loss	`NetIncomeLoss`	$-6.29M	USD	Annual
Net loss	`NetIncomeLoss`	$-2.97M	USD	Annual
Ending Balance	`StockholdersEquity`	$1.46M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$8.81M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$7.04M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.